164 related articles for article (PubMed ID: 2162094)
1. Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different glycoprotein-deleted Aujeszky's disease vaccines.
Pensaert MB; De Smet K; De Waele K
Vet Microbiol; 1990 Apr; 22(2-3):107-17. PubMed ID: 2162094
[TBL] [Abstract][Full Text] [Related]
2. Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines.
Vannier P; Hutet E; Bourgueil E; Cariolet R
Vet Microbiol; 1991 Nov; 29(3-4):213-23. PubMed ID: 1663287
[TBL] [Abstract][Full Text] [Related]
3. Virological protection of sows upon challenge with Aujeszky's disease virus after multiple vaccinations with attenuated or inactivated vaccines.
Nauwynck HJ; Zonnekeyn V; Pensaert MB
Zentralbl Veterinarmed B; 1997 Dec; 44(10):609-15. PubMed ID: 9467303
[TBL] [Abstract][Full Text] [Related]
4. Oronasal challenge of fattening pigs after vaccination with an inactivated Aujeszky's disease vaccine.
Pensaert MB; Vandeputte J; Andries K
Res Vet Sci; 1982 Jan; 32(1):12-6. PubMed ID: 6283610
[TBL] [Abstract][Full Text] [Related]
5. Influence of vaccination on Aujeszky's disease virus and disease transmission.
Donaldson AI; Wardley RC; Martin S; Harkness JW
Vet Rec; 1984 Aug; 115(6):121-4. PubMed ID: 6089404
[TBL] [Abstract][Full Text] [Related]
6. Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease.
van Oirschot JT; Gielkens AL; Moormann RJ; Berns AJ
Vet Microbiol; 1990 Jun; 23(1-4):85-101. PubMed ID: 2169682
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63.
van der Leek ML; Feller JA; Sorensen G; Isaacson W; Adams CL; Borde DJ; Pfeiffer N; Tran T; Moyer RW; Gibbs EP
Vet Rec; 1994 Jan; 134(1):13-8. PubMed ID: 8128561
[TBL] [Abstract][Full Text] [Related]
8. Air sampling procedure for evaluation of viral excretion level by vaccinated pigs infected with Aujeszky's disease (pseudorabies) virus.
Bourgueil E; Hutet E; Cariolet R; Vannier P
Res Vet Sci; 1992 Mar; 52(2):182-6. PubMed ID: 1316629
[TBL] [Abstract][Full Text] [Related]
9. Influence of passive immunity on pig immunization with deleted Aujeszky's disease vaccines measured by the amount of wild virus excretion after challenge.
Vannier P; Hutet E; Cariolet R
Vet Microbiol; 1995 Jan; 43(1):53-63. PubMed ID: 7716884
[TBL] [Abstract][Full Text] [Related]
10. Influence of vaccine medium and vaccination schedules on the induction of active immunity against Aujeszky's disease in maternally immune pigs.
De Smet K; De Waele K; Pensaert M
Res Vet Sci; 1994 Jan; 56(1):89-94. PubMed ID: 8146460
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of an intranasal immunization with gEgC and gEgI double-deletion mutants of Aujeszky's disease virus in maternally immune pigs and the effects of a successive intramuscular booster with commercial vaccines.
Nauwynck HJ; Labarque GG; Pensaert MB
Zentralbl Veterinarmed B; 1999 Dec; 46(10):713-22. PubMed ID: 10676150
[TBL] [Abstract][Full Text] [Related]
12. Intranasal vaccination of pigs against Aujeszky's disease: protective immunity at 2 weeks, 2 months and 4 months after vaccination in pigs with maternal antibodies.
van Oirschot JT
Vet Microbiol; 1991 Apr; 27(2):103-13. PubMed ID: 1648282
[TBL] [Abstract][Full Text] [Related]
13. Vaccines against Aujeszky's disease: comparison of efficacy, DNA fingerprints and antibody response to glycoprotein I.
van Oirschot JT; Gielkens AL
Vet Q; 1987 Nov; 9 Suppl 1():37S-49S. PubMed ID: 2829410
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity in Aujeszky's disease virus structural glycoprotein gVI (gp50) in swine.
Mukamoto M; Watanabe I; Kobayashi Y; Icatlo FC; Ishii H; Kodama Y
Vet Microbiol; 1991 Oct; 29(2):109-21. PubMed ID: 1660638
[TBL] [Abstract][Full Text] [Related]
15. Vaccines against Aujeszky's disease: evaluation of their efficacy under standardized laboratory conditions.
de Leeuw PW; van Oirschot JT
Vet Q; 1985 Jul; 7(3):191-7. PubMed ID: 2996210
[TBL] [Abstract][Full Text] [Related]
16. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs.
Gerdts V; Jöns A; Mettenleiter TC
Vet Microbiol; 1999 Mar; 66(1):1-13. PubMed ID: 10223318
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of three doses of the genetically engineered Aujeszky's disease virus vaccine strain 783 in pigs with maternal antibodies.
Kimman TG
Vaccine; 1992; 10(6):363-5. PubMed ID: 1317982
[TBL] [Abstract][Full Text] [Related]
18. Protection of fattening pigs against challenge with Aujeszky's disease virus after a successive intranasal/intramuscular vaccination.
Labarque GG; Nauwynck HJ; Maes DG; Pensaert MB
Vet Q; 1999 Jun; 21(3):104-7. PubMed ID: 10427636
[TBL] [Abstract][Full Text] [Related]
19. A novel concept for the control of Aujeszky's disease: experiences in two vaccinated pig herds.
van Oirschot JT; Wijsmuller JM; de Waal CA; van Lith PM
Vet Rec; 1990 Feb; 126(7):159-63. PubMed ID: 2155499
[TBL] [Abstract][Full Text] [Related]
20. Experimental infection of fattening pigs with pseudorabies (Aujeszky's disease) virus: efficacy of attenuated live- and inactivated-virus vaccines in pigs with or without passive immunity.
Vannier P
Am J Vet Res; 1985 Jul; 46(7):1498-502. PubMed ID: 2992327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
